{"summary":"Cancer therapy - Antibody-drug conjugates - Translational research - In vivo models \n\nEnthusiastic, committed, and discipline-driven Marie Curie Ph.D. student working at the Finsen Laboratory\/Biotech Research and Innovation Center in Copenhagen. \nI am a Medical Biotechnologist passionate about translational cancer research and immunotherapies. \nMy Ph.D. project aims at exploring the use of Antibody-drug conjugates targeting a key extracellular matrix receptor, the Urokinase Plasminogen Activator Receptor (uPAR) in pancreatic cancer.\n\nI always challenge myself and am eager to learn, trying to improve every day and critically learn from mistakes. I thrive in a team environment where I am regarded as an enthusiastic, precise, and methodical co-worker. My humble, but still confident and stubbornly, perseverant attitude allows me to realize my personal and professional goals and never give up.","lastName":"Metrangolo","objectUrn":"urn:li:member:482815951","geoRegion":"Copenhagen, Capital Region of Denmark, Denmark","fullName":"Virginia Metrangolo","firstName":"Virginia","currentPositions":[{"companyName":"Biotech Research & Innovation Centre (BRIC), University of Copenhagen","title":"Postdoctoral Researcher","tenureAtCompany":{"numYears":4,"numMonths":1},"companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"country":"Denmark","city":"Copenhagen","postalCode":"2200","line1":"Ole Maal\u00f8es Vej 5"},"website":"http:\/\/www.bric.ku.dk\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/biotech-research-and-innovation-centre-university-of-copenhagen\/","industry":"Biotechnology Research"},"startedOn":{"month":3,"year":2024},"companyUrn":"urn:li:fs_salesCompany:759958"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABzHL88BGxFzLwL4VkEmcyYJqNFI1pUWTmo,NAME_SEARCH,bxrC)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1647021593143?e=1723075200&v=beta&t=QGiclYb-aTsV_Drjv6ukDjEA758bcaGui5OSVVwUbXI","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1647021593143?e=1723075200&v=beta&t=9OULGxiEKmuGY5vTkawsCmeBqsFK4BafIJhZJc-uEJA","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1647021593143?e=1723075200&v=beta&t=qfYgSC-nx0RenmITI9jV2JTEBPGFIGxMhzHK9eumtcw","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1647021593143?e=1723075200&v=beta&t=s0RSfCfEgZnTAZ3X0hhXKHOGNZ2FMnkOAlYxwK5Ojw0","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4E03AQENdGmE9ZqZmw\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{"websites":[{"$anti_abuse_annotations":[{"attributeId":97,"entityId":19,"sourceUrn":"urn:li:member:482815951"},{"attributeId":48,"entityId":19,"sourceUrn":"urn:li:member:482815951"}],"category":"COMPANY","dataSource":"LINKEDIN","url":"https:\/\/imed.ku.dk\/research-areas-and-fellows\/virginia-metrangolo\/"}]},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2019},"degree":"Laurea Magistrale  LM","eduId":392619800,"schoolUrn":"urn:li:fs_salesSchool:15093769","school":"urn:li:fs_salesSchool:15093769","fieldsOfStudy":["Biotecnologie Mediche e Nanotecnologie"],"schoolName":"Universit\u00e0 del Salento","startedOn":{"year":2016}},{"endedOn":{"year":2015},"degree":"Triennale","eduId":330846913,"schoolUrn":"urn:li:fs_salesSchool:15093769","school":"urn:li:fs_salesSchool:15093769","fieldsOfStudy":["Biotecnologie"],"schoolName":"Universit\u00e0 degli Studi di Lecce","startedOn":{"year":2012}},{"endedOn":{"year":2012},"degree":"Maturit\u00e0 scientifica","schoolName":"Liceo Scientifico \"Cosimo de Giorgi\", Lecce","startedOn":{"year":2007},"eduId":333873984}],"skills":[{"numOfEndorsement":1,"name":"Antibody-drug conjugates"},{"numOfEndorsement":3,"name":"Cancer Immunotherapy"},{"numOfEndorsement":3,"name":"Targeted Drug Delivery"},{"numOfEndorsement":2,"name":"Mouse Models"},{"numOfEndorsement":0,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":1,"name":"Entrepreneurship"},{"numOfEndorsement":1,"name":"Project Management"},{"numOfEndorsement":8,"name":"PCR"},{"numOfEndorsement":7,"name":"Western blot"},{"numOfEndorsement":4,"name":"Elettroforesi su gel"},{"numOfEndorsement":6,"name":"Estrazione di DNA"},{"numOfEndorsement":4,"name":"Trasfezione"},{"numOfEndorsement":5,"name":"Scienza"},{"numOfEndorsement":6,"name":"Biotecnologia"},{"numOfEndorsement":5,"name":"Scienze naturali"},{"numOfEndorsement":8,"name":"Biologia molecolare"},{"numOfEndorsement":3,"name":"GC"},{"numOfEndorsement":4,"name":"HPLC"},{"numOfEndorsement":5,"name":"GMP"},{"numOfEndorsement":9,"name":"Industria farmaceutica"},{"numOfEndorsement":4,"name":"Coltura cellulare"},{"numOfEndorsement":3,"name":"Biochimica"},{"numOfEndorsement":3,"name":"Microbiologia"},{"numOfEndorsement":5,"name":"Norme di buona fabbricazione"},{"numOfEndorsement":3,"name":"SOP"},{"numOfEndorsement":3,"name":"Microsoft Excel"},{"numOfEndorsement":3,"name":"Chimica analitica"},{"numOfEndorsement":5,"name":"Controllo qualit\u00e0"}],"numOfConnections":903,"patents":[],"headline":"Medical biotechnologist","courses":[{"name":"\"Microbiota intestinale e salute dell'ospite: la nuova frontiera\""},{"name":"R&D Academy - Novo Nordisk","number":""},{"name":"Common Laboratory Mouse Strains: A Beginner's Guide","number":"The Jackson Laboratory"},{"name":"Ph.D. Course: Communication and Presentation in the academic context","number":"University of Copenhagen"},{"name":"\"Selecting immunodeficient mice for oncology and immuno-oncology research\" Charles River"},{"name":"In ViVo Pharmacology"},{"name":"Health Innovation and Entrepreneurship"},{"name":"Introduction to computational antibody engineering - Schrodinger"},{"name":"Innovation and intellectual property rights in Biotechnology"},{"name":"Introduction to Computational Antibody Engineering"}],"certifications":[{"authority":"Sanofi","name":"Human Error Prevention e corso di spegnimento degli incendi","company":"urn:li:fs_salesCompany:1642","startedOn":{"month":8,"year":2016},"companyUrn":"urn:li:fs_salesCompany:1642"},{"authority":"The Jackson Laboratory","name":"Certificate of Completion - Common Laboratory Mouse strains - Online MiniCourse","company":"urn:li:fs_salesCompany:17529","companyUrn":"urn:li:fs_salesCompany:17529"},{"authority":"The Jackson Laboratory","name":"Certificate of Completion -  Mutant and Transgenic Mouse Strains: A Beginner's Guide","company":"urn:li:fs_salesCompany:17529","companyUrn":"urn:li:fs_salesCompany:17529"},{"authority":"The Jackson Laboratory","name":"Certificate of Completion - Basics of CRISPR-Cas9","company":"urn:li:fs_salesCompany:17529","companyUrn":"urn:li:fs_salesCompany:17529"},{"authority":"The Jackson Laboratory","name":"Certificate of Completion -  Cre-Lox technology in Mouse Modeling","company":"urn:li:fs_salesCompany:17529","companyUrn":"urn:li:fs_salesCompany:17529"},{"authority":"Biotech Research & Innovation Centre (BRIC), University of Copenhagen","name":"Scientific project planning and management ","company":"urn:li:fs_salesCompany:759958","companyUrn":"urn:li:fs_salesCompany:759958"},{"authority":"K\u00f8benhavns Universitet - University of Copenhagen","name":"FELASA certification - A B D","company":"urn:li:fs_salesCompany:3540","startedOn":{"month":10,"year":2020},"companyUrn":"urn:li:fs_salesCompany:3540"},{"authority":"Charles River Laboratories","name":"Selecting immunodeficient mice for oncology and immuno-oncology research","company":"urn:li:fs_salesCompany:8306","companyUrn":"urn:li:fs_salesCompany:8306"}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/virginia-metrangolo-46783b115","organizations":[{"name":"European Association for Cancer Research","description":"The EACR is a professional membership association and\u00a0global community for those working and studying in cancer research, with more than 10,000 members\u00a0worldwide. Its mission is \u201cThe advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.","position":"Member"},{"name":"Antibody Society","position":"Member"}],"location":"Copenhagen, Capital Region of Denmark, Denmark","publications":[{"publishedOn":{"month":10,"day":27,"year":2021},"description":"Discovered more than three decades ago, the urokinase-type plasminogen activator receptor (uPAR) has now firmly established itself as a versatile molecular target holding promise for the treatment of aggressive malignancies. The copious abundance of uPAR in virtually all human cancerous tissues versus their healthy counterparts has fostered a gradual shift in the therapeutic landscape targeting this receptor from function inhibition to cytotoxic approaches to selectively eradicate the uPAR-expressing cells by delivering a targeted cytotoxic insult. Multiple avenues are being explored in a preclinical setting, including the more innovative immune- or stroma-targeting therapies. This review discusses the current state of these strategies, their potentialities, and challenges, along with future directions in the field of uPAR targeting.","url":"https:\/\/www.mdpi.com\/1331272","name":"The urokinase receptor as a \"trojan horse\"in targeted cancer therapy: challenges and opportunities","publisher":"Cancers","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABzHL88BGxFzLwL4VkEmcyYJqNFI1pUWTmo,NAME_SEARCH,bxrC)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAABZYPEBXyiga0RhilquQhKCSn8KyKLKC80,NAME_SEARCH,dUYz)"}]},{"name":"Antibody-drug conjugates","publisher":"\"Antibody-drug conjugates: the dynamic evolution from conventional to next-generation constructs\" , Cancers (MDPI)","url":"https:\/\/www.mdpi.com\/2072-6694\/16\/2\/447","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABzHL88BGxFzLwL4VkEmcyYJqNFI1pUWTmo,NAME_SEARCH,bxrC)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAABZYPEBXyiga0RhilquQhKCSn8KyKLKC80,NAME_SEARCH,dUYz)"}]}],"positions":null,"posts":[{"createdAt":1717166460000,"insightId":"78e578f8-2541-4e34-b12d-447963f92d5c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7199700143917383680,7202318311785660418)","threadUrn":"urn:li:activity:7199700143917383680","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":31,"length":9,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:274917826"}}}],"text":"Thank you for sharing our work L\u00e9a Valla and I am glad you appreciate the graphical abstract I made \ud83d\ude4f\u263a "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7199700143917383680"}}},{"createdAt":1717166460000,"insightId":"9dd34bfe-8c84-45e1-9a76-793822c777f0","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7202194666551721984,7202318395801751552)","threadUrn":"urn:li:activity:7202194666551721984","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks for sharing our work! \u263a\ud83d\ude4f"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7202194666551721984"}}},{"createdAt":1714814100000,"insightId":"bd363af3-2021-4388-a6db-63f475f6c79e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7190732268653457410,7192451752565112832)","threadUrn":"urn:li:ugcPost:7190732268653457410","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:278153335"}}},{"start":57,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:36807641"}}}],"text":"Alisa Wolberg I miss you all as well. I am waiting Prof. Matthew Flick to arrange a seminar and invite me over \ud83e\udd29\ud83d\ude42\ud83e\udd23\ud83c\udf08! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7190732268653457410"}}},{"createdAt":1714645680000,"insightId":"7879a055-7fea-4b4e-892d-503c0a6d4488","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7190732268653457410,7191745425656201216)","threadUrn":"urn:li:ugcPost:7190732268653457410","reactionsCount":2,"commentsCount":2,"canComment":true},"commentary":{"attributes":[{"start":18,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:278153335"}}}],"text":"Congratulations\ud83c\udf89 Alisa Wolberg you all look beautiful!!! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7190732268653457410"}}},{"createdAt":1710058740000,"insightId":"23a14fc4-c71a-414f-95c8-21d3a10ceabf","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7172506385937485824)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks Anne \u2764\ud83d\ude4f I am so glad you made it \u2764"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709971020000,"insightId":"a604604d-a6c1-43b2-bf10-89c5c5a8e0ad","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7172138318313283584)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks, dear \ud83c\udf37\ud83d\ude04"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709879040000,"insightId":"583327ad-6530-4bfb-b200-b4dd055a49fb","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7171752529091878912)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":19,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:971974683"}}}],"text":"Thank you so much, Gengcheng Jack Yang ! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709791200000,"insightId":"7d35764b-9498-43ad-957f-5021aa4f5097","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7171384286049251328)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Grazie mille, Alessandro! "},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709791200000,"insightId":"34ccb3b7-8ece-4cfa-8477-d7b22dbfe3ad","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7171384184945401856)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks, Ze \u263a\ud83d\ude4f\ud83c\udf37"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709614620000,"insightId":"fb3bd229-6df2-4cab-8eb0-ae71210aa3a1","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7170643566778638336)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks, Ashna \ud83d\ude4f\ud83c\udf37\u263a"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}},{"createdAt":1709555520000,"insightId":"5affd8a9-7f5b-4814-87e7-ad19ca99ffee","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7169709028330192896,7170395612922765313)","threadUrn":"urn:li:ugcPost:7169709028330192896","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thank you so much Lise!!! :) I still remember the first days in Peter\u00b4s group!!! :) <3"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7169709028330192896"}}}]}